GLP-1s for PCOS: what the evidence actually supports

What did @chanicenaomi actually say?

Honestly? It's hard to tell. The transcript from this video is almost entirely incoherent, likely the result of auto-generated captions failing to process Dutch speech. The caption states "hoe ik ben gestart voor pcos" which translates roughly to "how I started for PCOS," suggesting the creator was sharing a personal story about beginning some kind of treatment for polycystic ovary syndrome. Beyond that, the actual content is unrecoverable from this transcript. Phrases like "people from Mars and Air density" and repeated gym references appear to be mistranslations of Dutch audio.

What we can say: this video is tagged under GLP-1 receptor agonists and PCOS, and the creator appears to be a Dutch-speaking person documenting a personal health journey. The 35,700 views suggest real engagement. But without a readable transcript, any specific claim attribution would be fabricated on our part, and we won't do that.

Does the science back up GLP-1 use for PCOS?

This is actually worth addressing because it's why people are watching. GLP-1 receptor agonists have genuine, though still-evolving, evidence for PCOS management, particularly in women with insulin resistance or obesity. The data is more promising than most people realize.

A 2023 meta-analysis by Elkind-Hirsch et al. in Fertility and Sterility found that GLP-1 agonists like liraglutide and semaglutide significantly reduced BMI, improved menstrual regularity, and lowered androgen levels in women with PCOS compared to placebo. A 2022 randomized controlled trial by Jensterle et al. in Diabetes Care showed liraglutide outperformed metformin for weight loss and ovulatory function in obese PCOS patients. That said, most studies are small, short-term, and not yet powered to assess fertility outcomes or long-term hormonal normalization. The FDA has not approved any GLP-1 drug specifically for PCOS. Using one off-label for PCOS is a legitimate clinical decision, but it's not a settled question.

What did they get wrong or right?

We cannot fairly assign errors or credit to this specific creator because the transcript is not a reliable record of what was said. The video appears to be in Dutch, and the captions are machine-generated garbage. Attributing medical misinformation to someone based on a broken auto-transcription would itself be irresponsible.

What we can say about the broader category of PCOS-plus-GLP-1 content on TikTok: common errors in this space include claiming GLP-1 drugs cure PCOS (they don't, they manage symptoms in some patients), suggesting weight loss alone resolves all PCOS symptoms (it doesn't for many women, particularly lean PCOS subtypes), and implying that starting a GLP-1 without addressing insulin resistance or androgen levels is sufficient. If the creator avoided those claims, that would be a point in their favor. We simply can't verify it here.

What should you actually know?

If you have PCOS and you're considering a GLP-1, here's what the evidence actually supports. These medications can help with the insulin resistance component of PCOS, which affects roughly 70 percent of women with the condition according to Diamanti-Kandarakis and Dunaif (2012, Endocrine Reviews). Improved insulin sensitivity can, in turn, reduce androgen production from the ovaries and improve cycle regularity.

However, GLP-1 drugs are not a standalone PCOS treatment. They don't address all phenotypes equally, they carry real side effects including nausea, vomiting, and in rare cases pancreatitis, and they should be part of a broader clinical plan. Compounded versions of semaglutide or tirzepatide are not equivalent to brand-name Ozempic, Wegovy, Mounjaro, or Zepbound. Anyone pursuing this route should work with a licensed provider who can monitor hormone panels, not just body weight.

• GLP-1 agonists are not FDA-approved for PCOS specifically
• Evidence supports their use for insulin-resistant PCOS phenotypes, but data on lean PCOS is limited
• Menstrual regulation and androgen reduction have been observed in clinical trials, not just anecdotes
• These are prescription medications requiring proper medical oversight